April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Vision-related Quality of Life in patients with Ocular Graft-Versus-Host Disease
Author Affiliations & Notes
  • Tulio Batista Abud
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
  • Ujwala S Saboo
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
  • Francisco Amparo
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
  • Hasanain Shikari
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
  • Reza Dana
    Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Tulio Abud, None; Ujwala Saboo, None; Francisco Amparo, None; Hasanain Shikari, None; Reza Dana, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 174. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tulio Batista Abud, Ujwala S Saboo, Francisco Amparo, Hasanain Shikari, Reza Dana; Vision-related Quality of Life in patients with Ocular Graft-Versus-Host Disease. Invest. Ophthalmol. Vis. Sci. 2014;55(13):174.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To study the vision-related quality of life in a clinic-based cohort of patients with ocular Graft-Versus-Host Disease (GVHD).

Methods: One hundred patients were included in the study. Mean outcome measures included: the vision-related quality of life (QOL) score measured by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25); dry eye symptoms measured by the Ocular Surface Disease Index (OSDI©) and the Symptom Assessment in Dry Eye (SANDE) questionnaires; and clinical signs of dry eye, including corneal fluorescein staining, tear break up time (TBUT), Schirmer test, and meibomian gland dysfunction scores. We evaluated the degree of correlation between the scores of the different domains measured by the QOL questionnaire and the symptoms and clinical signs of dry eye.

Results: The mean composite NEI-VFQ score, which includes the domains evaluated in the questionnaire, was 75±18 ranging from 16 to 98 (where a score of 100 represents the best quality of life). The results of the NEI-VFQ revealed lower scores when compared to those reported for healthy controls. The most affected domains were: ocular pain 60 (healthy controls: 90), role functioning 63 (healthy controls: 93), mental health 66 (healthy controls: 92), and general health 47 (healthy controls: 69). There was a statistically significant correlation between the composite QOL score and the OSDI (R= -0.83; P<0.001), SANDE (R= -0.51; P<0.001), and corneal fluorescein staining (R= -0.36; P<0.001) scores. However, the QOL did not correlate with TBUT (R=0.17; P=0.1), Schirmer test (R=0.19; P=0.06) or meibomian gland dysfunction (lid margin telangiectasia [R=-0.08; P=0.5]; meibum quality [R=-0.05; P=0.7]) scores.

Conclusions: Patients with ocular GVHD present a reduction in their vision-related quality of life, particularly affecting the spheres of ocular pain, role functioning, mental health, and general health. Furthermore, symptoms of dry eye and corneal fluorescein staining are associated with the vision-related quality of life in these patients.

Keywords: 486 cornea: tears/tear film/dry eye  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×